Top compounds associated with response to DEFB106B


Feature Type Standardized
Nominal ANOVA
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.02 0.5
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC -0.019 0.5
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.019 0.5
mRNA SU11274 CTRPv2 pan-cancer AAC -0.021 0.5
mRNA clofarabine CTRPv2 pan-cancer AAC -0.017 0.5
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.021 0.5
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC -0.021 0.5
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.021 0.6
mRNA thalidomide CTRPv2 pan-cancer AAC -0.031 0.6
Download CSV